Sphingolipids as receptor modulators: An overview

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 57-71

  Yates, Allan J ^a,b   Rampersaud, Arfaan ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Graves Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; BETA 1 ADRENERGIC RECEPTOR; DELTA OPIATE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GLYCOLIPID; GLYCOPROTEIN; GLYCOSPHINGOLIPID; GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; MEMBRANE RECEPTOR; NERVE GROWTH FACTOR; OLIGOSACCHARIDE; SPHINGOLIPID; TYROSINE KINASE RECEPTOR;

CONFERENCE PAPER; DIMERIZATION; LIGAND BINDING; MEMBRANE BINDING; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 0031904515     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09662.x     Document Type: Article

References (97)

1. BECKER, L. E., T. W. PRIOR & A. J. YATES. 1997. Metabolic diseases. In Textbook of Neuropathology, R. L. Davis and D. M. Robertson, Eds.: 407-509. Williams and Wilkins, Baltimore.
2. PURPURA, D. P. & K. SUZUKI. 1976. Distorsion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 116:1-21.
3. WALKLEY, S. U, D. A. SIEGEL & K. DOBRENIS. 1995. GM2 ganglioside and pyramidal neuron dendritogenesis. Neurochem. Res. 20: 1287-1299.
4. RAHMANN, H. & R. HILBIG. 1983. Phylogenetical aspects of brain gangliosides in vertebrates. J. Comp. Physiol. 151: 215-223.
5. SVENNERHOLM, L., K. BOSTROM, P. FREDMAN, J.-E. MANSSON, B. ROSENGREN & B.-M. RYNMARK. 1989. Human brain gangliosides: Developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta 1005: 109-117.
6. ANDO, S. 1983. Gangliosides in the nervous system. Neurochem. Int. 5: 507-537.
7. STULTS, C. L. M., C. C. SWEELEY & B. A. MACHER. 1989. Glycosphingolipids: Structure, biological source, and properties. Methods Enzymol. 179: 167-214.
8. BECKER, K. & H. RAHMANN. 1995. Influence of ambient temperature on content and composition of brain gangliosides in vertebrates. Comp. Biochem. Physiol. [B], 111B: 299-310.
9. KAPPEL, T., R. HILBIG & H. RAHMANN. 1993. Variability in brain ganglioside content and composition of endothermic mammals, heterothermic hibernators and ectothermic fishes. Neurochem. Int. 22: 555-566.
10. SUNG, C. C., D. K. PEARL & A. J. YATES. 1993. Ganglioside composition of human brain tumors. J. Neurochem. 61: S232.
11. HAKOMORI, S. I. 1981. Glycosphinglipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50: 733-764.
12. LANGENBACH, R. & S. KENNEDY. 1978. Gangliosides and their cell density-dependent changes in control and chemically transformed C3H/10T1/2 cells. Exp. Cell Res. 112: 361-372.
13. LlEPKALNS, V. A., C. ICARD-LIEPKALNS, A. J. YATES, D. K. THOMPSON & R. W. HART. 1981. Effects of cell density on lipids of human glioma and fetal neural cells. J. Neurochem. 36: 1959-1965.
14. YATES, A. J., V. A. LIEPKALNS, C. ICARD-LIEPKALNS, F. JUNGALWALA, R. E. STEPHENS & R. W. HART. 1982. Effect of cell density on the neutral glycolipid composition of cultured human brain and glioma cells. Neurochem. Res. 7: 1269-1276.
15. ROSNER, H., C. CREIS & H. P. RODEMANN. 1990. Density-dependent expression of ganglioside GM3 by human skin fibroblasts in an all-or-none fashion, as a possible modulator of cell growth in vitro. Exp. Cell Res. 190: 161-169.
16. LEHNINGER, A. L. 1968. The neuronal membrane. Proc. Natl. Acad. Sci. USA 60: 1069-1080.
17. VAN HEYNINGEN, W. E. 1963. The fixation of tetanus toxin, strychnine, serotonin and other substances by ganglioside. J. Gen. Microbiol. 31: 375-387.
18. WINTER, A., W.-P. ULRICH, F. WETTERICH, U. WELLER & H.-J. GALLA. 1996. Gangliosides in phospholipid bilayer membranes: Interaction with tetanus toxin. Chem. Phys. Lipids 81: 21-34.
19. FRAZER, A. & J. G. HENSLER. 1993. Serotonin. In Basic Neurochemistry, G. J. Siegel, B. W. Agranoff, R. W. Albers, and P. B. Molinoff, Eds.: 283-308. Basic Neurochemistry. Raven Press. New York.
20. BESANCON, F. & H. ANKEL. 1974. Binding of Interferon to gangliosides. Nature 252: 478-480.
21. SCHIFFMANN, D. & K. KOSCHEL. 1981. Interferon induces an antiviral state in gangliosidedeficient transformed mouse fibroblasts. Med. Microbiol. Immunol. 169:281-289.
22. YATES, A. J., R. E. STEPHENS, P. J. ELDER, D. L. MARKOWITZ & J. M. RICE. 1985. Effects of interferon and gangliosides on growth of cultured human glioma and fetal brain cells. Cancer Res. 45: 1033-1039.
23. HOLMGREN, J.,I. LONNROTH & L. SVENNERHOLM. 1973. Tissue receptor for cholera exotoxin: Postulated structure from studies with GM1 ganglioside and related glycolipids. Infect. Immun. 8: 208-214.
24. YANG, L., C. B. ZELLER, N. L. SHAPER, M. KISO, A. HASEGAWA, R. E. SHAPIRO & R. L. SCHNAAR. 1996. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA 93: 814-818.
25. COLLINS, B. E., M. KISO, A. HASEGAWA, M. B. TROPAK, J. RODER, P. R. CROCKER & R. L. SCHNAAR. 1997. Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J. Bio. Chem. 272: 16889-16895.
26. RIOGOTT, M. J. & W. D. MATTHEW. 1996. Anti-idiotypic monoclonal antibodies to GM1 identify ganglioside binding proteins. Glycobiology 6: 581-589.
27. KEENAN, T. W., E. SCHMID, W. W. FRANKE & H. WIEGANDT. 1975. Exogenous glycosphingolipids suppress growth rate of transformed and untransformed 3T3 mouse cells. Exp. Cell Res. 92: 259-270.
28. PALLER, A. S., S. L. ARNSMEIER, M. ALVAREZ-FRANCO & E. G. BREMER. 1993. Ganglioside GM3 inhibits the proliferation of cultured keratinocytes. J. Invest. Dermatol. 100: 841-845.
29. ICARD-LIEPKALNS, C., V. A. LIEPKALNS, A. J. YATES, Z. R. RODRIGUEZ & R. E. STEPHENS. 1982. Effect of exogenous gangliosides on human neural cell division. J. Cell. Physiol. 113: 186-191.
30. SAQR, H. E., M.-C. LEE, A. M. BURKMAN & A. J. YATES. 1995. Gangliosides have a bimodal effect on DNA synthesis in U-1242 MG human glioma cells. J. Neurosci. Res. 41: 491-500.
31. BREMER, E. G. & S. I. HAKOMORI. 1982. GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: Ganglioside may regulate growth factor receptor function. Biochem. Biophys. Res. Commun. 106: 711-718.
32. MEUILLET, E., G. CREMEL, H. DREYFUS & D. HICKS. 1996. Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Muller glia. Glia 17: 206-216.
33. DE CRISTAN, G., L. MORBIDELLI, G. ALESSANDRI, M. ZICHE, A. P. M. CAPPA & P. M. GULLINO. 1990. Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. J. Cell. Physiol. 144: 505-510.
34. DIMPFEL, W., W. MOLLER & U. MENGS. 1981. Ganglioside-induced neurite formation in cultured cells. In Gangliosides in Neurological and Neuromuscular Function, Development and Repair, M. M. Rapport and A. Gorio, Eds.: 119-134. Raven Press. New York.
35. LEON, A., L. FACCI, D. BENVEGNU & G. TOFFANO. 1982. Morphological and biochemical effects of gangliosides in neuroblastoma cells. Dev. Neurosci. 5: 108-114.
36. FERRARI, G., M. FABRIS & A. GORIO. 1983. Gangliosides enhance neurite outgrowth in PC12 cells. Dev. Brain Res. 8: 215-221.
37. MURPHY, R. A., N. J. PANTAZIS, B. G. W. ARNASON & M. YOUNG. 1975. Secretion of a nerve growth factor by mouse neuroblastoma cells in culture. Proc. Natl. Acad. Sci. USA 72: 1895-1898.
38. BYRNE, M. C., R. W. LEDEEN, F. J. ROISEN, G. YORKE & J. R. SCLAFANI. 1983. Gangliosideinduced neuritogenesis: Verification that gangliosides are the active agents, and comparison of molecular species. J. Neurochem. 41: 1214-1221.
39. SCHENGRUND, C.-L. & C. PROUTY. 1988. Oligosaccharide portion of GM1 enhances process formation by S20Y neuroblastoma cells. J. Neurochem. 51: 277-282.
40. LEON, A., R. DAL Toso, D. PRESTI, D. BENVEGNU, L. FACCI, G. KIRSCHNER, G. TETTAMANTI & G. TOFFANO. 1988. Development and survival of neurons in dissociated fetal mesencephalic serum-free cell cultures: II. Modulatory effects of gangliosides. J. Neurosci. 8: 746-753.
41. MI ganglioside. Involvement of Trk neurotrophin receptors. J. Biol. Chem. 270: 3074-3080.
42. LIBERINI, P., E. P. PIORO, D. MAYSINGER, F. R. ERVIN & A. C. CUELLO. 1993. Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction. Neuroscience 53: 625-637.
43. SKAPER, D. S., L. FACCI, D. MILANI & A. LEON. 1989. Monosialoganglioside GM1 protects against anoxia-induced neuronal death in vitro. Exp. Neurol. 106: 294-305.
44. FONG, T.G., V. VOGELSBERG, N.H. NEFF & M. HADJICONSTANTINOU. 1995. GM1 and NGF synergism on choline acetyltransferase and choline uptake in aged brain. Neurobiol. Aging 16: 917-923.
45. WHISLER, R. L. & A. J. YATES. 1980. Regulation of lymphocyte responses by human gangliosides. Characteristics of inhibitory effects and the induction of impaired activation. J. Immunol. 125: 2106-2111.
46. LADISCH, S., H. BECKER &L. ULSH. 1992. Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim. Biophys. Acta 1125: 180-188.
47. MARCUS, D., A. DUSTIRA, I. DIEGO, S. Osovrrz & D. LEWIS. 1987. Studies of the mechanism by which gangliosides inhibit the proliferative response of murine splenocytes to concanavalin A 1. Cell. Immunol. 104: 71-78.
48. ROBB, R. 1986. The suppressive effect of gangliosides upon IL 2-dependent proliferation as a function of inhibition of IL 2-receptor association. J. Immunol. 136: 971-976.
49. HEITGER, A. & S. LADISCH. 1996. Gangliosides block antigen presentation by human monocytes. Biochim. Biophys. Acta 1303: 161-168.
50. ARAI, K., T. TAKI, A. KONDO & M. MATSUMOTO. 1988. Ganglioside GM3 as a modulator of differentiation of mouse myeloid leukemia cells (M1-T22). Cell Struct. Funct. 13: 161-169.
51. RÖSNER, H., M. AL-AQTUM, U. SONNENTAG, A. WURSTER & H. RAHMANN. 1992. Cell surface distribution of endogenous and effects of exogenous gangliosides on neuronal survival, cell shape and growth in vitro. Neurochem. Int. 20: 409-419.
52. ALESSANDRI, G., G. DE CRISTAN, M. ZICHE, A. P. M. CAPPA & P. M. GULLINO. 1992. Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium. J. Cell. Physiol. 151: 23-28.
53. MATYAS, G. R., D. C. EVERS, R. RADINSKY & D. J. MORRE. 1986. Fibronectin binding to gangliosides and rat liver plasma membranes. Exp. Cell Res. 162: 296-318.
54. THOMPSON, L. K., P. M. HOROWITZ, K. L. BENTLEY, D. D. THOMAS, J. F. ALDERETE & R. J. KLEBE. 1986. Localization of the ganglioside-binding site of fibronectin. J. Biol. Chem. 261: 5209-5214.
55. CHERESH, D. A. & F. G. KLIER. 1986. Disialoganglioside GD2 distributes preferentially into substrate-associated microprocesses on human melanoma cells during their attachment to fibronectin. J. Cell Biol. 102: 1887-1897.
56. CHERESH, D. A., M. D. PIERSCHBACHER, M. A. HERZIG & K. MUJOO. 1986. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102: 688-696.
57. CHERESH, D. A. 1987. Ganglioside involvement in tumor cell-substratum interactions. In Development and Recognition of the Transformed Cell, M. I. Greene and T. Hamaoka, Eds.: 407-428. Plenum. New York.
58. CHERESH, D. A., R. PYTELA, M. D. PIERSCHBACHER, F. G. KLIER, E. RUOSLAHTI & R. A. REISFELD. 1987. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in a divalent cation-dependent functional complex with the disialoganglioside GD2. J. Cell Biol. 105: 1163-1173.
59. ZHENG, M., H. FANG, T. TSURUOKA, T. TSUJI, T. SASAKI & S. HAKOMORI. 1993. Regulatory role of GM3 ganglioside in α5β1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. J. Biol. Chem. 268: 2217-2222.
60. COOLING, L. L. W., D. S. ZHANG, K. E. WALKER & T. A. W. KOERNER. 1995. Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins. Glycobiology 5: 571-581.
61. BREMER, E. G., S. I. HAKOMORI, D. F. BOWEN-POPE, E. RAINES & R. Ross. 1984. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J. Biol. Chem. 259: 6818-6825.
62. BREMER, E. G., J. SCHLESSINGER & S. I. HAKOMORI. 1986. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 of tryosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 261: 2434-2440.
63. HANAI, N., G. A. MORES, C. MACLEAD, C. R. TORRES-MENDEZ & S. HAKOMORI. 1988. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and Lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 263: 10915-10921.
64. SONG, W., M. F. VACCA, R. WELTI & D. A. RINTOUL. 1991. Effects of gangliosides GM3 and de-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth. J. Biol. Chem. 266: 10174-10181.
65. ZHOU, Q., S. HAKOMORI, K. KITAMURA & Y. IGARASHI. 1994. GM3 directly inhibits tyrosine phosphorylation and De-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J. Biol. Chem. 269: 1959-1965.
66. KASHLES, O., Y. YARDEN, R. FISCHER, A. ULLRICH & J. SCHLESSINGER. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11: 1454-1463.
67. WEIS, F. M. B. & R. J. DAVIS. 1990. Regulation of epidermal growth factor receptor signal transduction. Role of gangliosides. J. Biol. Chem. 265: 12059-12066.
68. PESTANA, E. S., U. GREISER, B. SANCHEZ, L. E. FERNANDEZ, A. LAGE, R. FEREZ & F.-D. BOHMER. 1997. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: Involvement of receptor-directed protein tyrosine phosphatase(s). Br. J. Cancer 75: 213-220.
69. HANAI, N., T. DOHI, G. A. NORESS & S.-I. HAKOMORI. 1988. A novel ganglioside, De-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J. Biol. Chem. 263: 6296-6301.
70. SONG, W., R. WELTI, S. HAFNER-STRAUSS & D. A. RINTOUL. 1993. Synthesis and characterization of N-parinaroyl analogs of ganglioside GM3 and de-N-acetyl GM3. Interactions with the EGF receptor kinase. Biochemistry 32: 8602-8607.
71. MINEO, C., G. L. JAMES, E. J. SMART & R. G. W. ANDERSON. 1996. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271: 11930-11935.
72. VAN BROOKLYN, J., E. G. BREMER & A. J. YATES. 1993. Gangliosides inhibit platelet-derived growth factor-stimulated receptor dimerization in human glioma U-1242MG and Swiss 3T3 Cells. J. Neurochem. 61: 371-374.
73. HYNDS, D. L., M. SUMMERS, J. VAN BROOKLYN, S. M. O'DORISO & A. J. YATES. 1995. Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J. Neurochem. 65: 2251-2258.
74. YATES, A. J., H. E. SAQR & J. VAN BROOKLYN. 1994. Ganglioside modulation of the PDGF receptor. A model for ganglioside function. J. Neuro-Oncol. In press.
75. YATES, A. J., J. VAN BROOKLYN, H. E. SAQR, Z. GUAN, B. T. STOKES & M. S. O'DORISIO. 1993. Mechanisms through which gangliosides inhibit PDGF-stimuIated mitogenesis in intact Swiss 3T3 cells: Receptor tyrosine phosphorylation, intracellular calcium, and receptor binding. Exp. Cell Res. 204: 38-45.
76. GUAN, Z., B. T. STOKES, J. VAN BROOKLYN & A. J. YATES. 1992. Gangliosides inhibit platelet-derived growth factor stimulated increases in intracellular calcium in Swiss 3T3 cells. Biochim. Biophys. Acta 1136: 315-318.
77. SAQR, H. E., J. D. WALTERS, Z. GUAN, B. T. STOKES & A. J. YATES. 1995. Gangliosides inhibit PDGF-induced signal transduction events in U-1242 MG human glioma cells. Neurochem. Res. 20: 1389-1395.
78. CHEN, W.-W., M. S. O'DORISIO, D. K. PEARL & A. J. YATES. 1992. Gangliosides inhibit platelet-derived growth factor stimulated growth of U-1242MG human glioma cells. Brain Tumor Pathol. 9: 51-54.
79. SACHINIDIS, A., R. KRAUS, C. SEUL, M. K. M. zu BRICKWEDDE, K. SCHULTE, Y. Ko, J. HOPPE & H. VETTER. 1996. Gangliosides GM1, GM2, and GM3 inhibit the platelet-derived growth-factor-induced signaling transduction pathway in vascular smooth muscle cells by different mechanisms. Eur. J. Cell Biol. 71: 79-88.
80. DECKERT, M., M. TICCHIONI & A. BERNARD. 1996. Endocytosis of GPI-anchored proteins in human lymphocytes: Role of glycolipid-based domains, actin cytoskeleton, and protein kinases. J. Cell Biol. 133: 791-799.
81. FRA, A. M., M. MASSERINI, P. PALESTINI, S. SONNINO & K. SIMONS. 1995. A photoreactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett. 375: 11-14.
82. Liu, P. S., Y. S. YING, Y. G. Ko & R. G. W. ANDERSON. 1996. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271: 10299-10303.
83. JING, S., P. TAPLEY & M. BARBACID. 1992. Nerve growth factor mediates signal transduction through Trk homodimer receptors. Neuron 9: 1067-1079.
84. ROVELLI, G., R. A. HELLER, M. CANOSSA & E. M. SHOOTER. 1993. Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells. Proc. Nat. Acad. Sci. USA 90: 8717-8721.
85. OBERMEIER, A., R. A. BRADSHAW, K. SEEDORF, A. CHOIDAS, J. SCHLESSINGER & A. ULLRICH. 1994. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLCg. EMBO J. 13: 1585-1590.
86. KAPLAN, D. R. & R. M. STEPHENS. 1994. Neurotrophin signal transduction by the Trk receptor. J. Neurobiol. 25: 1404-1417.
87. STEPHENS, R. M., D. M. LOEB, T. D. COPELAND, T. PAWSON, L. A. GREENE & D. R. KAPLAN. 1994. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gammal to mediate NGF responses. Neuron 12: 691-705.
88. SEGAL, R. A., A. BHATTACHARYYA, L. A. RUA, J. A. ALBERTA, R. M. STEPHENS, D. R. KAPLAN & C. D. STILES. 1996. Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 271: 20175-20181.
89. RABIN, S. J. & I. MOCCHETTI. 1995. GM1 ganglioside activates the high-affinity nerve growth factor receptor TrkA. J. Neurochem. 65: 347-354.
90. KOUHARA, H., Y. R. HADARI, T. SPIVAK-KROIZMAN, J. SCHILLING, D. BAR-SAGI, I. LAX & J. SCHLESSINGER. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89: 693-702.
91. SAQR, H. E., D. K. PEARL & A. J. YATES. 1993. A review and predictive models of ganglioside uptake by biological membranes: J. Neurochem. 61: 395-411.
92. MUTOH, T., T. TOKUDA, T. MIYADAI, M. HAMAGUCHI & N. FUJIKI. 1995. Ganglioside GM1 binds to Trk protein and regulates receptor function. Proc. Nat. Acad. Sci. USA 92: 5087-5091.
93. HIGASHI, H., S. YOSHIDA, K. SATO & T. YAMAGATA. 1996. Interaction of ganglioside with specific peptide sequences as a mechanism for the modulation of calmodulin-dependent enzymes. J. Biochem. (Tokyo) 120: 66-73.
94. LINGWOOD, C. A. 1996. Aglycone modulation of glycolipid receptor function. Glycoconjugate 113: 495-503.
95. FAROOQUI, T., T. FRANKLIN, D. K. PEARL & A. J. YATES. 1997. Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA. J. Neurochem. 68: 2348-2355.
96. NOJIRI, H., M. STROUD & S. HAKOMORI. 1991. A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity. Possible association of ganglioside-induced inhibition of insulin receptor function and monocytic differentiation induction in HL-60 cells. J. Biol. Chem. 266: 4531-4537.
97. HICKS, D., B. GUEROLD & H. DREYFUS. 1996. Stimulation of endogenous ganglioside metabolism by neurotrophic growth factors in cultured retinal Muller glia. Glia 16: 316-324.